Market Tracker

08/04 5:29am ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

108.74
Delayed Data
As of Aug 03
 +0.48 / +0.44%
Today’s Change
41.99
Today|||52-Week Range
109.95
+104.36%
Year-to-Date

Today’s Trading

Previous close108.26
Today’s open108.62
Day’s range107.89 - 108.95
Volume251,553
Average volume (3 months)396,584
Market cap$2.1B
Dividend yield--
Data as of 08/03/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+87.83%
Earnings growth (next 5 years)+46.08%
Revenue growth (last year)+31.78%
P/E ratio216.7
Price/Sales17.67
Price/Book80.52

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc-0.13-0.22%
MDCOMedicines Co-0.38-1.21%
PRTAProthena Corporation...+1.67+2.53%
GLPGGalapagos NV+1.55+2.56%
Data as of 08/03/2015

Financials

Last reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.82
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts